Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Current liabilities changed +65.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Total assets changed +75.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Revenue changed -100.0% from the comparable as-filed period.
Current assets changed +68.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Working capital changed +68.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cost of revenue changed -100.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross profit changed +100.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital / assets changed -298 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Shares outstanding changed +23.4% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
Stock-based compensation changed +30.1% from the comparable as-filed period.
Operating income changed -9.2% from the comparable as-filed period.
Free-cash-flow proxy changed +5.6% from the comparable as-filed period.
Operating cash flow changed +5.6% from the comparable as-filed period.
Research & development changed +10.4% from the comparable as-filed period.
Current ratio changed +1.7% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capital expenditure changed +0.0% from the comparable as-filed period.
Total assets changed +67.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed -28.6% from the comparable as-filed period.
Working capital changed +83.7% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current assets changed +71.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Shares outstanding changed +24.0% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Cost of revenue changed -58.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed -11.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed -31.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating cash flow changed -11.2% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Current ratio changed +109.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Stock-based compensation changed +36.2% from the comparable as-filed period.
Working capital / assets changed +830 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Current liabilities changed -18.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Capital expenditure changed +60.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Gross profit changed +312.9% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
Revenue changed from 0 to 158000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Research & development changed +9.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.